CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 152 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $71,725,058 | +33.1% | 1,937,991 | +51.0% | 0.19% | +43.5% |
| Q1 2024 | $53,880,960 | -50.7% | 1,283,797 | -53.4% | 0.13% | -50.4% |
| Q4 2023 | $109,307,799 | +195.9% | 2,756,122 | +105.3% | 0.26% | +144.4% |
| Q3 2023 | $36,942,848 | -8.1% | 1,342,400 | +13.3% | 0.11% | -10.0% |
| Q2 2023 | $40,200,264 | +386.8% | 1,184,800 | +416.2% | 0.12% | +361.5% |
| Q1 2023 | $8,257,518 | -63.4% | 229,503 | -54.6% | 0.03% | -66.2% |
| Q4 2022 | $22,543,506 | +494.0% | 505,800 | +274.7% | 0.08% | +413.3% |
| Q3 2022 | $3,795,000 | +299.5% | 135,000 | +192.8% | 0.02% | +275.0% |
| Q1 2021 | $950,000 | – | 46,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,388,967 | $125,425,669 | 9.68% |
| 5AM Venture Management, LLC | 497,270 | $18,403,963 | 4.12% |
| COMMODORE CAPITAL LP | 1,425,000 | $52,739,250 | 3.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 374,910 | $13,875,419 | 3.27% |
| TSP Capital Management Group, LLC | 249,220 | $9,223,635 | 2.89% |
| Eventide Asset Management | 3,327,132 | $123,137,155 | 2.11% |
| Affinity Asset Advisors, LLC | 475,400 | $17,594,554 | 2.03% |
| Novo Holdings A/S | 850,000 | $31,458,500 | 1.83% |
| Bellevue Group AG | 2,971,615 | $109,979,471 | 1.79% |
| Redmile Group, LLC | 718,723 | $26,599,938 | 1.61% |